Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hours in Human Immunodeficiency Virus-Infected Patients

Human immunodeficiency virus (HIV) patients on nucleoside or nucleotide reverse transcriptase inhibitors with HIV RNA at <1,000 copies/ml were randomized in an open-label study to administration of combined indinavir/ritonavir (IDV/RTV) at 667/100 mg every 12 h (q12h) or IDV alone at 800 mg q8h t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rhame, Frank S., Rawlins, Sandy L., Petruschke, Richard A., Erb, Tara A., Winchell, Gregory A., Wilson, Helene M., Edelman, Jonathan M., Abramson, Murray A.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC525412/
https://ncbi.nlm.nih.gov/pubmed/15504842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.11.4200-4208.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares